Plant Nano-Vesicles Show Promise for Skin Aging, Hair Loss, and Wound Healing

The skin is simultaneously the body's largest organ and one of its most challenging targets for drug delivery. The stratum corneum blocks most pharmaceutical agents, while conditions including photoaging, alopecia, pigmentation disorders, and chronic wounds impose enormous clinical burden. Conventional treatments—topical agents, lasers, surgery, and cell therapies—are limited by poor penetration, adverse effects, and patient non-adherence, creating demand for smarter delivery platforms.

Plant-derived exosome-like nanovesicles (PENs) are naturally secreted extracellular vesicles, 50–500 nm in diameter, isolated from a wide range of botanical sources including ginger, garlic, grapes, bitter melon, sunflower seeds, and tea. Their lipid bilayer is enriched in phosphatidic acid (PA), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and galactolipids—but notably lacks cholesterol. This distinct lipid composition contributes to membrane flexibility, gastrointestinal stability, and specific tissue-targeting behavior. PENs also carry low but functionally active protein loads (including surface lectins that mediate receptor-dependent cellular uptake via proteins like CD98), plant microRNAs, and bioactive small molecules such as polyphenols and flavonoids.

Biogenesis occurs through three identified pathways. The primary multivesicular body (MVB) pathway mirrors mammalian exosome formation: plasma membrane invagination creates early endosomes that mature into MVBs via the ESCRT machinery; these fuse with the plasma membrane to release intraluminal vesicles as exosomes. The plant-specific EXPO (exocyst-positive organelle) pathway involves double-membraned autophagosomelike structures that fuse directly with the plasma membrane, releasing single-membrane vesicles implicated in innate immunity signaling. The vacuolar pathway, linked to pathogen defense, involves vacuoles secreting hydrolases and antimicrobial proteins extracellularly, and may also contribute to PEN generation.

In dermatological applications, PENs exert effects across four major domains. For skin aging, their antioxidant cargo neutralizes reactive oxygen species generated by UV exposure, while lipid components stimulate collagen synthesis and inhibit matrix metalloproteinases. For alopecia, PENs have been shown to activate hair follicle stem cells and modulate Wnt/β-catenin and other growth pathways. In pigmentation disorders, PEN contents can suppress tyrosinase activity and downregulate melanogenesis signaling, offering a natural alternative to synthetic depigmenting agents. For wound healing, PENs promote keratinocyte migration, angiogenesis, and anti-inflammatory macrophage polarization, accelerating tissue repair in preclinical models.

Despite these promising attributes, several translational barriers must be addressed. Standardized isolation protocols (differential ultracentrifugation, size-exclusion chromatography, density-gradient methods) vary across studies, limiting reproducibility. Long-term in vivo toxicology and pharmacokinetic data are sparse, particularly for topical and systemic routes beyond oral delivery. Manufacturing scalability, batch consistency, and regulatory classification (as drug, biologic, or cosmetic) remain unresolved. Additionally, while surface engineering with targeting ligands can improve tissue specificity, these modifications add complexity and cost.